| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCYT | Common Stock | Award | $0 | +21.4K | +38.67% | $0.00 | 76.8K | Aug 5, 2022 | Direct | F1, F2 | 
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCYT | Common Stock | Award | $0 | +36.5K | $0.00 | 36.5K | Aug 5, 2022 | Stock Option (right to buy) | 36.5K | $27.90 | Direct | F3 | 
| Id | Content | 
|---|---|
| F1 | Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. | 
| F2 | Includes 624 shares of common stock purchased on July 29, 2022 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. | 
| F3 | The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. |